Bruker (NASDAQ:BRKR) reported quarterly earnings results on February 12, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.59, missing the consensus estimate of $0.66 by $0.07 per share. Revenue came in at $977.2M, beating the estimate of $965.3M.
Bruker's stock moved following the earnings release. The stock currently trades at $36.85 with a market capitalization of $7.0B.


